$OCGN nice continuation today, closed at 14.61. Shares trading higher after its COVID vaccine shows effectiveness against the Brazilian variant, B.1.128.2, first identified in April 2020. Previous study also indicated it could protect against variants from the U.K and India. Company recently tweeted about its vaccine cited Dr Fauci. Dr Fauci stated 'Covaxin found to neutralize Indian 617 Variant. The WHO recently listed B.1.617 as a 'variant of interest' and said it had been found in 17 countries. White House recently announced it would immediately make specific raw materials needed by India to make COVID-19 vaccines, current Indian manufacture of the Covishield vaccine, AstraZeneca $AZS developed with Oxford University will immediately be made available for India. Covaxin, is another vaccine available in India, developed by Hyderabad-based Bharat Biotech and has collaboration agreement with OCGN, Pennsylvania-based - pending U.S EUA approval.
1
1
11
11 Likes